Key result
Ethanol withdrawal in chronic alcoholics increased ADP-stimulated platelet TXB2 formation to markedly higher levels than in nonalcoholic controls at 9-14 days.
Why the study?
Does ethanol withdrawal affect platelet thromboxane formation capacity in chronic alcoholics compared to healthy controls?
Observational (n=14)
Does ethanol withdrawal affect platelet thromboxane formation capacity in chronic alcoholics compared to healthy controls?
Ethanol withdrawal in chronic alcoholics leads to a rebound increase in ADP-stimulated platelet thromboxane formation, suggesting a potential transient pro-thrombotic state.
Answers are grounded in this paper and cite their sources.
Rebound TXB2 rise may signal transient prothrombotic risk in withdrawing alcoholics; hypothesis-generating and requires prospective validation.
Collagen-, arachidonate- and ADP-stimulated platelet thromboxane B2 (TXB2) formation was studied in platelet-rich plasma (PRP) of 14 alcoholics, 7 of whom had a biopsy-verified alcoholic fatty liver. On admission for detoxication, the alcoholics showed decreased platelet count and aggregability (p less than 0.001) as compared to nonalcoholic healthy controls. Platelet TXB2 formation was decreased (p less than 0.01), if PRP was stimulated by arachidonate, but not if it was stimulated by ADP or collagen. In contrast, 9-14 days after ethanol withdrawal platelet TXB2 formation had increased to markedly higher levels than those seen in nonalcoholic controls (p less than 0.01), if PRP was stimulated by ADP, but not if it was stimulated by arachidonate or collagen. Skin bleeding time was found to be prolonged (p less than 0.05) on admission in alcoholics having fatty liver, but it normalized within 2 weeks after ethanol withdrawal. We conclude that the effect of ethanol withdrawal in alcoholics on platelet TXB2 formation is influenced by platelet count, aggregability and the agonist used to induce platelet aggregation.
No takes yet. Share an insight, caveat, or question.
Hillbom et al. (2009) conducted an observational in Chronic alcoholism (n=14). Ethanol withdrawal vs. Nonalcoholic healthy controls was evaluated on Platelet thromboxane B2 (TXB2) formation (p=<0.01). Ethanol withdrawal in chronic alcoholics increased ADP-stimulated platelet TXB2 formation to markedly higher levels than in nonalcoholic controls at 9-14 days.
Synapse has enriched 10 related papers. Consider them for comparative context: